These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34249371)

  • 21. HCI-modelling for improving the clinical usability of digital health technologies.
    Paton C; Borycki EM; Warren J; Kushniruk AW; English M
    Methods; 2024 Jul; 227():60-77. PubMed ID: 38729456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Financial interests of patient organisations contributing to technology assessment at England's National Institute for Health and Care Excellence: policy review.
    Mandeville KL; Barker R; Packham A; Sowerby C; Yarrow K; Patrick H
    BMJ; 2019 Jan; 364():k5300. PubMed ID: 30651227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach.
    Haig M; Main C; Chávez D; Kanavos P
    Value Health; 2023 Oct; 26(10):1474-1484. PubMed ID: 37385445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NICE's social value judgements about equity in health and health care.
    Shah KK; Cookson R; Culyer AJ; Littlejohns P
    Health Econ Policy Law; 2013 Apr; 8(2):145-65. PubMed ID: 22717361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telling the story of complex change: an Impact Framework for the real world.
    Willett J; Barclay M; Mukoro F; Sweeney G
    Int J Qual Health Care; 2021 Jul; 33(3):. PubMed ID: 34100552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NICE guidance in the Scottish context.
    Kohli H; Tannahill A
    Scott Med J; 2009 Feb; 54(1):35-8. PubMed ID: 19291935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing Theory-Driven, Evidence-Based Serious Games for Health: Framework Based on Research Community Insights.
    Verschueren S; Buffel C; Vander Stichele G
    JMIR Serious Games; 2019 May; 7(2):e11565. PubMed ID: 31045496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spotlight on COVID-19 rapid guidance: NICE's experience of producing rapid guidelines during the pandemic.
    Southall S; Taske N; Power E; Desai M; Baillie N
    J Public Health (Oxf); 2021 Apr; 43(1):e103-e106. PubMed ID: 33150447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Institute for Health and Clinical Excellence: the Medical Technologies Evaluation Programme.
    J Med Eng Technol; 2011 Jul; 35(5):283-4. PubMed ID: 21635177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating environmental considerations in digital health technology assessment and procurement: Stakeholders' perspectives.
    Alami H; Rivard L; Lehoux P; Ag Ahmed MA; Fortin JP; Fleet R
    Digit Health; 2023; 9():20552076231219113. PubMed ID: 38074337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
    Getsios D; Migliaccio-Walle K; Caro JJ
    Pharmacoeconomics; 2007; 25(12):997-1006. PubMed ID: 18047386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the implementation of NICE public health workplace guidance: an evaluation of the effectiveness of action-planning workshops in NHS trusts in England.
    Jones S; Sloan D; Evans HE; Williams S
    J Eval Clin Pract; 2015 Aug; 21(4):567-71. PubMed ID: 25756499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
    Dietrich ES
    Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review.
    Taylor A; Staruchowicz L
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-22. PubMed ID: 27820153
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.